Antagonists of Growth Hormone-Releasing Hormone Inhibit the Growth of Pituitary Adenoma Cells by Hampering Oncogenic Pathways and Promoting Apoptotic Signaling
Pituitary adenomas (PAs) are intracranial tumors, often associated with excessive hormonal secretion and severe comorbidities. Some patients are resistant to medical therapies; therefore, novel treatment options are needed. Antagonists of growth hormone-releasing hormone (GHRH) exert potent anticanc...
Main Authors: | Iacopo Gesmundo, Giuseppina Granato, Antonio C. Fuentes-Fayos, Clara V. Alvarez, Carlos Dieguez, Maria Chiara Zatelli, Noemi Congiusta, Dana Banfi, Nunzia Prencipe, Sheila Leone, Luigi Brunetti, Justo P. Castaño, Raúl M. Luque, Renzhi Cai, Wei Sha, Ezio Ghigo, Andrew V. Schally, Riccarda Granata |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/16/3950 |
Similar Items
-
Evaluation of Factors Affecting Outcome in Growth Hormone–Secreting Pituitary Adenomas
by: Amit Padwal, et al.
Published: (2017-09-01) -
Treatment experience of intractable headache in patients with growth hormone ⁃ secreting pituitary adenoma
by: Yi⁃ding FENG, et al.
Published: (2020-03-01) -
Dual treatment of acromegaly and hormone-receptor-positive breast cancer with tamoxifen: a case report
by: Sasan Mirfakhraee, et al.
Published: (2021-04-01) -
Assessment of anthropometric and physical health indicators before and after pituitary surgery in patients with nonfunctioning pituitary adenomas, acromegaly, and Cushing disease
by: Cyro G S. Leães, et al.
Published: (2019-01-01) -
Preoperative treatment of growth hormone (GH) producing macroadenomas with somatostatin receptor ligands (SRLs) to improve surgical outcome: a critical analysis
by: Ariel Barkan
Published: (2018-07-01)